MétaCan
Menu
← Back to cohort
Record W4394950864 · doi:10.1101/2024.04.18.24306021

The Probability of Reducing Hospitalization Rates for Bronchiolitis: A Bayesian Analysis

2024· preprint· en· W4394950864 on OpenAlexafffundabout
Larry Dong, Terry P. Klassen, David W. Johnson, Rhonda Correll, Serge Gouin, Maala Bhatt, Hema Patel, Gary Joubert, Karen Black, Troy Turner, Sandra Whitehouse, Amy C. Plint, Anna Heath

Bibliographic record

VenuemedRxiv · 2024
Typepreprint
Languageen
FieldMedicine
TopicRespiratory viral infections research
Canadian institutionsUniversity of AlbertaUniversity of British ColumbiaBC Children's HospitalCentre Hospitalier Universitaire Sainte-JustineChildren's Hospital Research Institute of ManitobaStollery Children's HospitalAlberta Children's HospitalHospital for Sick ChildrenUniversité de MontréalUniversity of SaskatchewanChildren's Hospital of Western OntarioChildren's Hospital of Eastern OntarioUniversity of CalgaryMcGill UniversityMcGill University Health CentreUniversity of OttawaInstitute for Clinical Evaluative SciencesPublic Health OntarioWestern UniversityUniversity of Toronto
FundersCanada Research ChairsCanadian Institutes of Health ResearchUniversity of Ottawa
KeywordsBayesian probabilityBronchiolitisStatisticsEconometricsMathematicsEnvironmental scienceMedicineInternal medicine

Abstract

fetched live from OpenAlex

Structured Abstract Background Bronchiolitis exerts a high burden on children, their families and the healthcare system. The Canadian Bronchiolitis Epinephrine Steroid Trial (CanBEST) assessed whether administering epinephrine alone, dexamethasone alone, or in combination (EpiDex) could reduce bronchiolitis-related hospitalizations among children less than 12 months of age compared to placebo. CanBEST demonstrated a statistically significant reduction in 7-day hospitalization risk with EpiDex in an unadjusted analysis but not after adjustment. Objective To explore the probability that EpiDex results in a reduction in hospitalizations using Bayesian methods. Study Design Using prior distributions that represent varying levels of preexisting enthusiasm or skepticism and information about the treatment effect before data were collected, the Bayesian distribution of the relative risk of hospitalization compared to placebo was determined. The probability that the treatment effect is less 1, 0.9, 0.8 and 0.6, indicating increasing reductions in hospitalization risk, are computed alongside 95% credible intervals. Results Combining a minimally informative prior distribution with the data from CanBEST provides comparable results to the original analysis. Unless strongly skeptical views about the effectiveness of EpiDex were considered, the 95% credible interval for the treatment effect lies below 1, indicating a reduction in hospitalizations. There is a 90% probability that EpiDex results in a clinically meaningful reduction in hospitalization of 10% even when incorporating skeptical views, with a 67% probability when considering strongly skeptical views. Conclusion A Bayesian analysis demonstrates a high chance that EpiDex reduces hospitalization rates for bronchiolitis, although strongly skeptical individuals may require additional evidence to change practice.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.069
metaresearch head score (Gemma)0.220
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Simulation or modeling · Consensus signal: Simulation or modeling
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.069
Threshold uncertainty score0.366

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0690.220
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0040.005
Bibliometrics0.0030.002
Science and technology studies0.0010.004
Scholarly communication0.0030.002
Open science0.0030.002
Research integrity0.0030.004
Insufficient payload (model declined to judge)0.0090.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.043
GPT teacher head0.392
Teacher spread0.349 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSimulation or modeling
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes3
Has abstractyes

Explore more

Same venuemedRxiv→Same topicRespiratory viral infections research→French-language works237,207→